StockWatch
·

OMKAR PHARMACHEM LTD. Q4 FY25 Results

OMKARPHQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue0.140.0%
Total Income0.141.5%
Expenditure0.0968.1%
PBT0.0544.0%
Net Profit-0.02125.3%
OPM49.04%
NPM-15.93%77.97pp
EPS0.0275.0%
View full financials

Informational and educational content only. Not investment advice.